albendazole has been researched along with Granulomas in 24 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Albendazole therapy has been found effective in solitary cysticercus granuloma." | 9.16 | Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial. ( Garg, RK; Khurana, N; Malhotra, HS; Shukla, R; Singh, MK; Verma, R, 2012) |
| "Use of Albendazole therapy for the treatment of patients having persisting intracranial solitary cysticercus granuloma is controversial." | 9.09 | Albendazole therapy for solitary persistent cysticercus granuloma. ( Arora, A; Lal, V; Prabhakar, S; Sawhney, IM; Thussu, A, 2001) |
| "We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days." | 9.07 | Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. ( Rajshekhar, V, 1993) |
| "Seizures are the primary clinical manifestation which could be acute (secondary to active lesions) or remote symptomatic (due to calcified lesions)." | 5.40 | Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis. ( Chakrabarty, B; Gulati, S; Gupta, AK; Jain, P; Kumar, A; Pandey, RM; Sachan, D, 2014) |
| "Albendazole therapy has been found effective in solitary cysticercus granuloma." | 5.16 | Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial. ( Garg, RK; Khurana, N; Malhotra, HS; Shukla, R; Singh, MK; Verma, R, 2012) |
| "We conducted a double-blind, placebo-controlled trial in which 120 patients who had living cysticerci in the brain and seizures treated with antiepileptic drugs were randomly assigned to receive either 800 mg of albendazole per day and 6 mg of dexamethasone per day for 10 days (60 patients) or two placebos (60 patients)." | 5.11 | A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. ( Del Brutto, OH; Evans, CA; Garcia, HH; Gilman, RH; Gonzalez, AE; Herrera, G; Martinez, SM; Moulton, LH; Pretell, EJ, 2004) |
| "In children, intracranial granuloma diagnosed on computerized tomography (CT) scan and presenting with seizures as the sole manifestation has traditionally been treated with antitubercular (ATB) therapy or albendazole (Alb) in addition to antiepileptic drugs (AED)." | 5.09 | Does treatment change the outcome of seizures and computerized tomographic lesions in intracranial granulomas? ( Kanhere, S; Mehta, R; Naik, N; Rajadhyaksha, S; Shah, KN, 1999) |
| "Use of Albendazole therapy for the treatment of patients having persisting intracranial solitary cysticercus granuloma is controversial." | 5.09 | Albendazole therapy for solitary persistent cysticercus granuloma. ( Arora, A; Lal, V; Prabhakar, S; Sawhney, IM; Thussu, A, 2001) |
| "We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days." | 5.07 | Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. ( Rajshekhar, V, 1993) |
| "Anthelminthic treatment with albendazole provides improved rates of seizure freedom and hastens resolution of the granuloma." | 4.89 | Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. ( Otte, WM; Sander, JW; Singh, G; Singla, M, 2013) |
| "Seizures are the commonest manifestation of brain parenchymal cysticercosis." | 2.55 | Controversies in the treatment of seizures associated with neurocysticercosis. ( Sharma, R; Singh, G, 2017) |
| "Seizures are the primary clinical manifestation which could be acute (secondary to active lesions) or remote symptomatic (due to calcified lesions)." | 1.40 | Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis. ( Chakrabarty, B; Gulati, S; Gupta, AK; Jain, P; Kumar, A; Pandey, RM; Sachan, D, 2014) |
| "Ocular Toxocariasis is a parasitosis caused by Toxocara catis/canis larvae localized in the eye." | 1.40 | [Ocular toxocariasis--case report]. ( Brănişteanu, D; Costin, D; Moraru, A; Panfil, M; Schmitzer, S; Totolici, G, 2014) |
| "However, recurrence of seizures can be expected in about 15% of patients." | 1.32 | Seizure outcome in patients with a solitary cerebral cysticercus granuloma. ( Jeyaseelan, L; Rajshekhar, V, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, G | 3 |
| Sharma, R | 1 |
| Trabelsi, H | 1 |
| Néji, S | 1 |
| Cheikhrouhou, F | 1 |
| Sellami, H | 1 |
| Guidara, R | 1 |
| Mhiri, W | 1 |
| Makni, F | 1 |
| Ayadi, A | 1 |
| Gulati, S | 1 |
| Jain, P | 1 |
| Sachan, D | 1 |
| Chakrabarty, B | 1 |
| Kumar, A | 1 |
| Pandey, RM | 1 |
| Gupta, AK | 1 |
| Moraru, A | 1 |
| Panfil, M | 1 |
| Totolici, G | 1 |
| Brănişteanu, D | 1 |
| Costin, D | 1 |
| Schmitzer, S | 1 |
| Zhao, BC | 1 |
| Jiang, HY | 1 |
| Ma, WY | 1 |
| Jin, DD | 1 |
| Li, HM | 1 |
| Lu, H | 1 |
| Nakajima, H | 1 |
| Huang, TY | 1 |
| Sun, KY | 1 |
| Chen, SL | 1 |
| Chen, KB | 1 |
| Chaurasia, RN | 1 |
| Garg, RK | 3 |
| Agarwall, A | 1 |
| Kohli, N | 1 |
| Verma, R | 2 |
| Singh, MK | 2 |
| Shukla, R | 2 |
| Taylor, MJ | 1 |
| Hoerauf, A | 1 |
| Bockarie, M | 1 |
| Ooi, WW | 1 |
| Wijemanne, S | 1 |
| Thomas, CB | 1 |
| Quezado, M | 1 |
| Brown, CR | 1 |
| Nash, TE | 1 |
| Khurana, N | 1 |
| Malhotra, HS | 1 |
| Maeda, T | 1 |
| Ito, A | 1 |
| Sako, Y | 1 |
| Yamasaki, H | 1 |
| Oyaizu, N | 1 |
| Odawara, T | 1 |
| Iwamoto, A | 1 |
| Fujii, T | 1 |
| Otte, WM | 1 |
| Singla, M | 1 |
| Sander, JW | 1 |
| Levine, DJ | 1 |
| Riley, DJ | 1 |
| Jorgensen, JH | 1 |
| McClain, WD | 1 |
| Tio, F | 1 |
| Visvesvara, GS | 1 |
| Abboud-Werner, SL | 1 |
| Conway, KP | 1 |
| Denholm, RB | 1 |
| Harrison, GA | 1 |
| O'Riordan, B | 1 |
| Garcia, HH | 1 |
| Pretell, EJ | 1 |
| Gilman, RH | 1 |
| Martinez, SM | 1 |
| Moulton, LH | 1 |
| Del Brutto, OH | 2 |
| Herrera, G | 1 |
| Evans, CA | 1 |
| Gonzalez, AE | 1 |
| Sotelo, J | 1 |
| Rajshekhar, V | 4 |
| Jeyaseelan, L | 1 |
| Rajadhyaksha, S | 1 |
| Shah, KN | 1 |
| Kanhere, S | 1 |
| Naik, N | 1 |
| Mehta, R | 1 |
| Sobti, P | 1 |
| Bhatia, RS | 1 |
| Singh, D | 1 |
| Thussu, A | 1 |
| Arora, A | 1 |
| Lal, V | 1 |
| Prabhakar, S | 1 |
| Sawhney, IM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2021-01-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for albendazole and Granulomas
| Article | Year |
|---|---|
Controversies in the treatment of seizures associated with neurocysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Anticonvulsants; Choice Behavior; Consensus; Epilepsy; Granulo | 2017 |
Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Albendazole; Animals; Anthelmintics; Child; Cysticercus; Drug T | 2016 |
Lymphatic filariasis and onchocerciasis.
Topics: Africa South of the Sahara; Age Factors; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal | 2010 |
Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Calcinosis; Child; Child, Preschoo | 2013 |
6 trials available for albendazole and Granulomas
| Article | Year |
|---|---|
Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study.
Topics: Adolescent; Adult; Albendazole; Anticestodal Agents; Anticonvulsants; Child; Child, Preschool; Doubl | 2010 |
Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Cysticercus; Drug A | 2012 |
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Anticonvulsants | 2004 |
Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.
Topics: Adolescent; Adult; Albendazole; Animals; Brain Diseases; Cysticercosis; Cysticercus; Female; Granulo | 1993 |
Does treatment change the outcome of seizures and computerized tomographic lesions in intracranial granulomas?
Topics: Adolescent; Albendazole; Anthelmintics; Anticonvulsants; Antitubercular Agents; Brain Diseases; Chil | 1999 |
Albendazole therapy for solitary persistent cysticercus granuloma.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Female; Granuloma; Humans; Male; Middle Aged; | 2001 |
14 other studies available for albendazole and Granulomas
| Article | Year |
|---|---|
[Ocular toxocariasis: a case report].
Topics: Albendazole; Anthelmintics; Blepharoptosis; Eye Infections, Parasitic; Fluorescein Angiography; Gran | 2014 |
Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis.
Topics: Albendazole; Anthelmintics; Anticonvulsants; Child; Child, Preschool; Female; Follow-Up Studies; Gra | 2014 |
[Ocular toxocariasis--case report].
Topics: Adult; Albendazole; Animals; Anthelmintics; Diagnosis, Differential; Endophthalmitis; Granuloma; Hum | 2014 |
Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Calcinosis; Edema; Granuloma; Humans; Levetira | 2011 |
Neurocysticercosis case with tuberculoma-like epithelioid granuloma strongly suspected by serology and confirmed by mitochondrial DNA.
Topics: Albendazole; Animals; Anthelmintics; Biopsy; Contrast Media; Diagnosis, Differential; DNA, Mitochond | 2011 |
Key diagnostic features of granulomatous interstitial nephritis due to Encephalitozoon cuniculi in a lung transplant recipient.
Topics: Albendazole; Antifungal Agents; Encephalitozoon cuniculi; Encephalitozoonosis; Fatal Outcome; Granul | 2013 |
Granulomatous peritonitis in hydatid disease.
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis, Hepatic; Echinococcus; Female; Granuloma; Human | 2003 |
Neurocysticercosis--is the elimination of parasites beneficial?
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Follow-Up Studies; Granuloma; Humans; Neurocystice | 2004 |
Seizure outcome in patients with a solitary cerebral cysticercus granuloma.
Topics: Adolescent; Adult; Albendazole; Anticestodal Agents; Anticonvulsants; Child; Child, Preschool; Femal | 2004 |
Albendazole therapy in patients with solitary cerebral cysticercus granuloma. Is it effective?
Topics: Albendazole; Anthelmintics; Brain Diseases; Granuloma; Humans; Neurocysticercosis; Research Design | 2008 |
Solitary cysticercus granulomas.
Topics: Albendazole; Animals; Brain Diseases; Cysticercosis; Granuloma; Humans; Seizures; Tomography, X-Ray | 1995 |
Cysticercus granuloma.
Topics: Albendazole; Cysticercosis; Granuloma; Humans; Time Factors; Tomography, X-Ray Computed | 1994 |
Enlarging single CT lesions can also spontaneously resolve.
Topics: Adolescent; Albendazole; Anthelmintics; Brain; Child; Granuloma; Humans; Male; Seizures; Tomography, | 2000 |
Cerebral cysticercus granuloma associated with a subdural effusion.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Epilepsy; Female; Granuloma; Humans; Magnetic Res | 2001 |